[1]
E. . Patel, “Hexokinase Activator Attenuates Type 2 Diabetes Mellitus and Associated Endothelial Dysfunction in HFF-STZ-Induced Diabetic Rat: Pharmaceutical Science-Pharmacy”, Int J Life Sci Pharm Res, vol. 13, no. 1, pp. P98-P104, Dec. 2022.